Innovation1 Biotech Inc. (IVBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Nov 3, 2025
Innovation1 Biotech Company Description
Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products.
The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products.
It also develops NLC001 that is in Phase II clinical trial for the treatment of long covid and other viral indications.
The company is based in New York, New York.
Innovation1 Biotech Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 1 |
| CEO | Francis Knuettel |
Contact Details
Address: 169 Madison Ave New York, New York 10016 United States | |
| Phone | 212 292 3115 |
| Website | i1bio.com |
Stock Details
| Ticker Symbol | IVBT |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| ISIN Number | US39809D1028 |
| SIC Code | 9995 |
Key Executives
| Name | Position |
|---|---|
| Francis Knuettel II, M.B.A. | Executive Chairman and Interim Chief Executive Officer |
| Samuel J. Knipper | Chief Financial Officer |
| Tammy Phillips | Managing Director |